NasdaqGS - Delayed Quote USD

Biomea Fusion, Inc. (BMEA)

10.77 -0.21 (-1.91%)
At close: April 24 at 4:00 PM EDT
11.54 +0.77 (+7.15%)
Pre-Market: 5:10 AM EDT
Loading Chart for BMEA
DELL
  • Previous Close 10.98
  • Open 11.00
  • Bid 10.73 x 800
  • Ask 10.80 x 600
  • Day's Range 10.44 - 11.24
  • 52 Week Range 8.12 - 43.69
  • Volume 751,203
  • Avg. Volume 1,048,338
  • Market Cap (intraday) 386.529M
  • Beta (5Y Monthly) -0.54
  • PE Ratio (TTM) --
  • EPS (TTM) -3.44
  • Earnings Date Apr 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 54.43

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.

biomeafusion.com

103

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BMEA

Performance Overview: BMEA

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BMEA
25.83%
S&P 500
6.33%

1-Year Return

BMEA
64.61%
S&P 500
22.70%

3-Year Return

BMEA
35.89%
S&P 500
21.33%

5-Year Return

BMEA
--
S&P 500
21.17%

Compare To: BMEA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BMEA

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    386.53M

  • Enterprise Value

    219.96M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.28

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -1.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -47.89%

  • Return on Equity (ttm)

    -84.42%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -117.25M

  • Diluted EPS (ttm)

    -3.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    176.87M

  • Total Debt/Equity (mrq)

    6.08%

  • Levered Free Cash Flow (ttm)

    -62.19M

Research Analysis: BMEA

Analyst Price Targets

30.00
54.43 Average
10.77 Current
90.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: BMEA

Fair Value

10.77 Current
 

Dividend Score

0 Low
BMEA
Sector Avg.
100 High
 

Hiring Score

0 Low
BMEA
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
BMEA
Sector Avg.
100 High
 

Research Reports: BMEA

  • Daily – Vickers Top Buyers & Sellers for 06/05/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 05/18/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 04/27/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 04/07/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch